Francesco Forconi, MD

Selecting the Appropriate CAR T-Cell Therapy for Patients with R/R LBCL

Is There a Potential Role for Rapcabtagene Autoleucel in R/R LBCL?

PD-1 Inhibitor Combinations, Alternative Therapeutic Approaches Are Moving the Needle in NSCLC

Better Understanding of Biomarkers Can Inform Immunotherapy Treatment in SCLC